Last 12 months
Inside the activity.
0 purchase rows · 279 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 31 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 111 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 106 |
| Apr 2026 | 0 | 14 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
SaleCommon Stock | 440 | $243.23 | $107,021.20 |
DisclosureSEC source: 0001735276-25-000023 · edgardoc.xml · nonDerivative · entry 8 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,761 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.87 to $243.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
SaleCommon Stock | 1,093 | $242.44 | $264,986.92 |
DisclosureSEC source: 0001735276-25-000023 · edgardoc.xml · nonDerivative · entry 7 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,201 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.86 to $242.86. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
SaleCommon Stock | 461 | $241.51 | $111,336.11 |
DisclosureSEC source: 0001735276-25-000023 · edgardoc.xml · nonDerivative · entry 6 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,294 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $240.85 to $241.85. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
SaleCommon Stock | 284 | $240.32 | $68,250.88 |
DisclosureSEC source: 0001735276-25-000023 · edgardoc.xml · nonDerivative · entry 5 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,755 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $239.82 to $240.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
SaleCommon Stock | 127 | $239.18 | $30,375.86 |
DisclosureSEC source: 0001735276-25-000023 · edgardoc.xml · nonDerivative · entry 4 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,039 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $238.73 to $239.69. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
SaleCommon Stock | 123 | $238.33 | $29,314.59 |
DisclosureSEC source: 0001735276-25-000023 · edgardoc.xml · nonDerivative · entry 3 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,166 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $237.72 to $238.72. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:32 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
SaleCommon Stock | 158 | $236.51 | $37,368.58 |
DisclosureSEC source: 0001735276-25-000023 · edgardoc.xml · nonDerivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,289 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $236.50 to $237.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
SaleCommon Stock | 59 | $244.11 | $14,402.49 |
DisclosureSEC source: 0001735276-25-000022 · edgardoc.xml · nonDerivative · entry 9 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,898 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F9 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $243.90 to $244.32. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
SaleCommon Stock | 121 | $243.23 | $29,430.83 |
DisclosureSEC source: 0001735276-25-000022 · edgardoc.xml · nonDerivative · entry 8 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,957 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.87 to $243.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
SaleCommon Stock | 300 | $242.44 | $72,732.00 |
DisclosureSEC source: 0001735276-25-000022 · edgardoc.xml · nonDerivative · entry 7 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,078 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.86 to $242.86. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
SaleCommon Stock | 127 | $241.51 | $30,671.77 |
DisclosureSEC source: 0001735276-25-000022 · edgardoc.xml · nonDerivative · entry 6 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,378 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $240.85 to $241.85. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
SaleCommon Stock | 78 | $240.32 | $18,744.96 |
DisclosureSEC source: 0001735276-25-000022 · edgardoc.xml · nonDerivative · entry 5 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,505 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $239.82 to $240.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
SaleCommon Stock | 35 | $239.18 | $8,371.30 |
DisclosureSEC source: 0001735276-25-000022 · edgardoc.xml · nonDerivative · entry 4 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,583 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $238.73 to $239.69. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
SaleCommon Stock | 34 | $238.33 | $8,103.22 |
DisclosureSEC source: 0001735276-25-000022 · edgardoc.xml · nonDerivative · entry 3 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,618 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $237.72 to $238.72. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
SaleCommon Stock | 42 | $236.51 | $9,933.42 |
DisclosureSEC source: 0001735276-25-000022 · edgardoc.xml · nonDerivative · entry 2 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,652 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $236.50 to $237.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 38 | $244.11 | $9,276.18 |
DisclosureSEC source: 0001735276-25-000021 · edgardoc.xml · nonDerivative · entry 9 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,345 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F9 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $243.90 to $244.32. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 78 | $243.23 | $18,971.94 |
DisclosureSEC source: 0001735276-25-000021 · edgardoc.xml · nonDerivative · entry 8 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,383 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.87 to $243.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 192 | $242.44 | $46,548.48 |
DisclosureSEC source: 0001735276-25-000021 · edgardoc.xml · nonDerivative · entry 7 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,461 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.86 to $242.86. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 82 | $241.51 | $19,803.82 |
DisclosureSEC source: 0001735276-25-000021 · edgardoc.xml · nonDerivative · entry 6 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,653 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $240.85 to $241.85. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 50 | $240.32 | $12,016.00 |
DisclosureSEC source: 0001735276-25-000021 · edgardoc.xml · nonDerivative · entry 5 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,735 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $239.82 to $240.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 23 | $239.18 | $5,501.14 |
DisclosureSEC source: 0001735276-25-000021 · edgardoc.xml · nonDerivative · entry 4 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,785 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $238.73 to $239.69. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 22 | $238.33 | $5,243.26 |
DisclosureSEC source: 0001735276-25-000021 · edgardoc.xml · nonDerivative · entry 3 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,808 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $237.72 to $238.72. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 28 | $236.51 | $6,622.28 |
DisclosureSEC source: 0001735276-25-000021 · edgardoc.xml · nonDerivative · entry 2 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,830 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $236.50 to $237.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 69 | $244.11 | $16,843.59 |
DisclosureSEC source: 0001735276-25-000020 · edgardoc.xml · nonDerivative · entry 9 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,962 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F9 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $243.90 to $244.32. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 142 | $243.23 | $34,538.66 |
DisclosureSEC source: 0001735276-25-000020 · edgardoc.xml · nonDerivative · entry 8 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,031 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.87 to $243.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 352 | $242.44 | $85,338.88 |
DisclosureSEC source: 0001735276-25-000020 · edgardoc.xml · nonDerivative · entry 7 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,173 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.86 to $242.86. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 149 | $241.51 | $35,984.99 |
DisclosureSEC source: 0001735276-25-000020 · edgardoc.xml · nonDerivative · entry 6 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,525 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $240.85 to $241.85. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 91 | $240.32 | $21,869.12 |
DisclosureSEC source: 0001735276-25-000020 · edgardoc.xml · nonDerivative · entry 5 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,674 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $239.82 to $240.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 41 | $239.18 | $9,806.38 |
DisclosureSEC source: 0001735276-25-000020 · edgardoc.xml · nonDerivative · entry 4 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,765 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $238.73 to $239.69. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 40 | $238.33 | $9,533.20 |
DisclosureSEC source: 0001735276-25-000020 · edgardoc.xml · nonDerivative · entry 3 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,806 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $237.72 to $238.72. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:31 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 51 | $236.51 | $12,062.01 |
DisclosureSEC source: 0001735276-25-000020 · edgardoc.xml · nonDerivative · entry 2 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,846 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $236.50 to $237.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:30 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 37 | $244.11 | $9,032.07 |
DisclosureSEC source: 0001735276-25-000019 · edgardoc.xml · nonDerivative · entry 8 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,385 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of a tranche of restricted stock units granted to the reporting person on February 27, 2023. F9 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $243.90 to $244.32. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:30 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 75 | $243.23 | $18,242.25 |
DisclosureSEC source: 0001735276-25-000019 · edgardoc.xml · nonDerivative · entry 7 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,422 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of a tranche of restricted stock units granted to the reporting person on February 27, 2023. F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.87 to $243.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:30 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 187 | $242.44 | $45,336.28 |
DisclosureSEC source: 0001735276-25-000019 · edgardoc.xml · nonDerivative · entry 6 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,497 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of a tranche of restricted stock units granted to the reporting person on February 27, 2023. F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.86 to $242.86. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:30 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 79 | $241.51 | $19,079.29 |
DisclosureSEC source: 0001735276-25-000019 · edgardoc.xml · nonDerivative · entry 5 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,684 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of a tranche of restricted stock units granted to the reporting person on February 27, 2023. F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $240.85 to $241.85. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:30 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 48 | $240.32 | $11,535.36 |
DisclosureSEC source: 0001735276-25-000019 · edgardoc.xml · nonDerivative · entry 4 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,763 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of a tranche of restricted stock units granted to the reporting person on February 27, 2023. F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $239.82 to $240.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:30 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 22 | $239.18 | $5,261.96 |
DisclosureSEC source: 0001735276-25-000019 · edgardoc.xml · nonDerivative · entry 3 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,811 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of a tranche of restricted stock units granted to the reporting person on February 27, 2023. F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $238.73 to $239.69. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:30 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 21 | $238.33 | $5,004.93 |
DisclosureSEC source: 0001735276-25-000019 · edgardoc.xml · nonDerivative · entry 2 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,833 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of a tranche of restricted stock units granted to the reporting person on February 27, 2023. F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $237.72 to $238.72. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:30 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 27 | $236.51 | $6,385.77 |
DisclosureSEC source: 0001735276-25-000019 · edgardoc.xml · nonDerivative · entry 1 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,854 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of a tranche of restricted stock units granted to the reporting person on February 27, 2023. F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $236.50 to $237.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:32 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000023 · edgardoc.xml · derivative · entry 11 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,921 Underlying: Common Stock · 5,921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. F12 · derivative.exercise_date: On February 27, 2023, the reporting person was granted 17,763 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 27, 2025, the second tranche of restricted stock units from the February 27, 2023 grant vested and was released, as reported on this Form 4. F12 · derivative.expiration_date: On February 27, 2023, the reporting person was granted 17,763 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 27, 2025, the second tranche of restricted stock units from the February 27, 2023 grant vested and was released, as reported on this Form 4. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:32 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 5,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000023 · edgardoc.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:31 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000022 · edgardoc.xml · derivative · entry 11 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,908 Underlying: Common Stock · 1,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. F12 · derivative.exercise_date: On February 27, 2023, the reporting person was granted 5,724 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 27, 2025, the second tranche of restricted stock units from the February 27, 2023 grant vested and was released, as reported on this Form 4. F12 · derivative.expiration_date: On February 27, 2023, the reporting person was granted 5,724 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 27, 2025, the second tranche of restricted stock units from the February 27, 2023 grant vested and was released, as reported on this Form 4. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:31 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 1,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000022 · edgardoc.xml · nonDerivative · entry 1 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:31 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000021 · edgardoc.xml · derivative · entry 10 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,666 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. F11 · derivative.exercise_date: On February 27, 2023, the reporting person was granted 5,000 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 27, 2025, the second tranche of restricted stock units from the February 27, 2023 grant vested and was released, as reported on this Form 4. F11 · derivative.expiration_date: On February 27, 2023, the reporting person was granted 5,000 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 27, 2025, the second tranche of restricted stock units from the February 27, 2023 grant vested and was released, as reported on this Form 4. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:31 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000021 · edgardoc.xml · nonDerivative · entry 1 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:31 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
Exercise / conversionRestricted Stock Units · Derivative | 1,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000020 · edgardoc.xml · derivative · entry 12 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,908 Underlying: Common Stock · 1,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_price: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. F13 · derivative.exercise_date: On February 27, 2023, the reporting person was granted 5,724 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 27, 2025, the second tranche of restricted stock units from the February 27, 2023 grant vested and was released, as reported on this Form 4. F13 · derivative.expiration_date: On February 27, 2023, the reporting person was granted 5,724 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 27, 2025, the second tranche of restricted stock units from the February 27, 2023 grant vested and was released, as reported on this Form 4. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:31 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
Exercise / conversionCommon Stock | 1,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000020 · edgardoc.xml · nonDerivative · entry 1 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2025 Filed Feb 18, 2025 21:47 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 83 | $259.10 | $21,505.30 |
DisclosureSEC source: 0001735276-25-000010 · edgardoc.xml · nonDerivative · entry 18 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,881 F13 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024. Read SEC document |
| February 18, 2025 Filed Feb 18, 2025 21:47 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 76 | $257.79 | $19,592.04 |
DisclosureSEC source: 0001735276-25-000010 · edgardoc.xml · nonDerivative · entry 17 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,964 F13 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024. Read SEC document |
| February 18, 2025 Filed Feb 18, 2025 21:47 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 80 | $256.05 | $20,484.00 |
DisclosureSEC source: 0001735276-25-000010 · edgardoc.xml · nonDerivative · entry 16 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,040 F13 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024. F15 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $256.00 to $256.95. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.